• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The inflammatory and nutritional status in patients with dilated cardiomyopathy: Different impact for distinct phenogroups?

作者信息

Lerchner Tobias, Fender Anke, Dobrev Dobromir, Rassaf Tienush, Michel Lars

机构信息

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Germany.

Institute of Pharmacology, West German Heart and Vascular Center, University Hospital Essen, Germany.

出版信息

Int J Cardiol Heart Vasc. 2025 Jan 18;56:101610. doi: 10.1016/j.ijcha.2025.101610. eCollection 2025 Feb.

DOI:10.1016/j.ijcha.2025.101610
PMID:39882169
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11775409/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0598/11775409/5b412dfc8648/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0598/11775409/5b412dfc8648/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0598/11775409/5b412dfc8648/gr1.jpg

相似文献

1
The inflammatory and nutritional status in patients with dilated cardiomyopathy: Different impact for distinct phenogroups?扩张型心肌病患者的炎症和营养状况：对不同表型组有不同影响？
Int J Cardiol Heart Vasc. 2025 Jan 18;56:101610. doi: 10.1016/j.ijcha.2025.101610. eCollection 2025 Feb.
2
Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences.扩张型心肌病患者的表型聚类突出了重要的病理生理差异。
Eur Heart J. 2021 Jan 7;42(2):162-174. doi: 10.1093/eurheartj/ehaa841.
3
The HFA-PEFF score identifies 'early-HFpEF' phenogroups associated with distinct biomarker profiles.HFA-PEFF 评分可识别与不同生物标志物特征相关的“早期-HFpEF”表型群。
ESC Heart Fail. 2022 Jun;9(3):2032-2036. doi: 10.1002/ehf2.13861. Epub 2022 Mar 17.
4
Advanced echocardiography and cluster analysis to identify secondary tricuspid regurgitation phenogroups at different risk.先进的超声心动图和聚类分析以识别不同风险下的继发性三尖瓣反流表型组。
Rev Esp Cardiol (Engl Ed). 2025 Feb 21. doi: 10.1016/j.rec.2025.02.004.
5
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.射血分数保留的心力衰竭中的临床表型组：详细表型、预后及对螺内酯的反应
JACC Heart Fail. 2020 Mar;8(3):172-184. doi: 10.1016/j.jchf.2019.09.009. Epub 2020 Jan 8.
6
[Detection of enteroviral RNA in endomyocardial biopsies in inflammatory cardiomyopathy and idiopathic dilated cardiomyopathy].[炎症性心肌病和特发性扩张型心肌病心内膜心肌活检中肠道病毒RNA的检测]
Z Kardiol. 1998 Jun;87(6):443-52. doi: 10.1007/s003920050199.
7
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data.利用电子健康记录数据对射血分数保留或轻度降低的心衰进行表型分组。
BMC Cardiovasc Disord. 2024 Jul 5;24(1):343. doi: 10.1186/s12872-024-03987-9.
8
Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease.心肌钙非依赖性一氧化氮合酶活性存在于扩张型心肌病、心肌炎和产后心肌病中，但不存在于缺血性或瓣膜性心脏病中。
Br Heart J. 1995 Oct;74(4):426-30. doi: 10.1136/hrt.74.4.426.
9
Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes.临床表型分组比左心室射血分数分类更能有效分层心力衰竭结局。
ESC Heart Fail. 2021 Aug;8(4):2741-2754. doi: 10.1002/ehf2.13344. Epub 2021 May 2.
10
Occurrence of nutritional hypocalcaemic rickets-related dilated cardiomyopathy in a child with concomitant rickets and infantile-onset Pompe disease.一名患有佝偻病和婴儿型庞贝病的儿童出现与营养性低钙血症佝偻病相关的扩张型心肌病。
Cardiol Young. 2019 Mar;29(3):425-427. doi: 10.1017/S1047951118002287. Epub 2019 Jan 25.

本文引用的文献

1
Prognostic value of preoperative high-sensitivity C-reactive protein to albumin ratio in patients with dilated cardiomyopathy receiving pacemaker therapy: A retrospective two-center study in China.术前高敏C反应蛋白与白蛋白比值对接受起搏器治疗的扩张型心肌病患者的预后价值：一项中国的回顾性双中心研究
Int J Cardiol Heart Vasc. 2024 Nov 16;55:101554. doi: 10.1016/j.ijcha.2024.101554. eCollection 2024 Dec.
2
Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy.左心室舒张功能障碍会使扩张型心肌病所致心力衰竭患者的预后恶化。
ESC Heart Fail. 2025 Apr;12(2):1183-1193. doi: 10.1002/ehf2.15119. Epub 2024 Nov 4.
3
The emerging role of clonal haematopoiesis in the pathogenesis of dilated cardiomyopathy.
克隆性造血在扩张型心肌病发病机制中的新作用。
Eur Heart J. 2024 Oct 17;45(45):4797-807. doi: 10.1093/eurheartj/ehae682.
4
Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine.扩张型心肌病的病理生理学：从机制到精准医学
Nat Rev Cardiol. 2025 Mar;22(3):183-198. doi: 10.1038/s41569-024-01074-2. Epub 2024 Oct 11.
5
Dilated cardiomyopathy: second hits knock-down the heart.扩张型心肌病：二次打击击垮心脏。
Eur Heart J. 2024 Feb 16;45(7):500-501. doi: 10.1093/eurheartj/ehad778.
6
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.《2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》2023年聚焦更新
Eur Heart J. 2023 Oct 1;44(37):3627-3639. doi: 10.1093/eurheartj/ehad195.
7
2023 ESC Guidelines for the management of cardiomyopathies.2023年欧洲心脏病学会心肌病管理指南。
Eur Heart J. 2023 Oct 1;44(37):3503-3626. doi: 10.1093/eurheartj/ehad194.
8
Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial.病毒阴性炎性心肌病的免疫抑制治疗：TIMIC 试验 20 年随访。
Eur Heart J. 2022 Sep 21;43(36):3463-3473. doi: 10.1093/eurheartj/ehac348.
9
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study.针对心力衰竭患者的新型靶向微小RNA-132反义疗法：首例人体1b期随机、双盲、安慰剂对照研究结果
Eur Heart J. 2021 Jan 7;42(2):178-188. doi: 10.1093/eurheartj/ehaa898.
10
Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences.扩张型心肌病患者的表型聚类突出了重要的病理生理差异。
Eur Heart J. 2021 Jan 7;42(2):162-174. doi: 10.1093/eurheartj/ehaa841.